Detalles de la búsqueda
1.
Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.
Oncologist
; 24(6): e232-e240, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30413667
2.
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports.
Oncology
; 94 Suppl 1: 34-44, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30041178
3.
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 73, 2023 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37684252
4.
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
Ther Adv Med Oncol
; 13: 17588359211059873, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35173816
5.
Incidence of invasive cervical cancer and direct costs associated with its management in Italy.
Tumori
; 95(2): 146-52, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19579858
6.
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 10(1): 13, 2024 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316819
7.
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 89, 2023 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37903774
8.
Communicating cancer diagnosis and prognosis: when the target is the elderly patient-a GIOGer study.
Eur J Cancer
; 45(3): 374-83, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18838268
Resultados
1 -
8
de 8
1
Próxima >
>>